Consisting of Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, Maryland,¬†New York, Rhode Island, and Vermont, the northeast region is considered the most affluent region in the United States and has more than 54 million people.¬†Northeast venture capital firms are leaders in the industry and have backed a large amount of seed and early stage businesses within the fields of information technology, biotechnology, high-tech manufacturing,¬†research and development, and pharmaceuticals.¬†Northeast capital can range from $25,000 to $15 million through traditional venture capital/private equity firms or angel investors.
Similar to¬†west coast venture capital,¬†northeast funding has proven critical to creating the sustainability of the region.¬†Although activity for early and¬†late stage¬†funding is high, northeast private equity including later stage financing, buyouts, and mezzanine funding is also important in the investor community.
Submit your¬†business plan to FindVenture.com to get access to regional investors.
Greylock Partners¬†provides early stage¬†funding and growth equity to¬†companies worldwide.¬† With $2 billion in capital under management, the firm has invested in¬†businesses such as Facebook, LinkedIn, and Pandora.¬† Established in 1965, Greylock Partners has¬†operations in the United States, China, Israel, and India.
Canaan Partners is an multi-stage venture capital firm backing companies around the world in the technology and healthcare arena including digital media, clean technology, medical devices, and biopharmaceuticals. Canaan Partners has invested in more than 250 companies worldwide with¬†funding amounts ranging from¬†$1 million to $20 million¬†for early to late stage¬†needs.
Highland Capital Partners was formed in 1988 and operates a number of funds with a total commitment of more than $3 billion in invested capital to date.¬† The funds focus on seed, early, and growth stage companies in information and communications technology, Internet and digital media, healthcare, and consumer markets.
New Leaf Venture Partners is a multi-stage venture capital firm with more than $1 billion in capital and a portfolio of 45 companies.¬† It focuses on the healthcare technology sector including biopharmaceuticals, medical devices, diagnostic, and infrastructure technologies. New Leaf Venture Partners represents a true player in healthcare private equity. The firm is currently investing its second fund totaling $450 million.
Village Ventures specializes in the media/consumer and financial services industries, and focuses on opportunities in San Francisco and Boston as well as nationwide.¬† Companies within their portfolio include Carefx, Babble, and ScholarOne.
New Enterprise Associates is a multi-stage venture capital firm supporting companies in diverse phases from seed stage to growth equity, and has funded more than 650 organizations worldwide.¬† The company has more than $11 billion in invested capital with companies in the IT, healthcare, and energy technology industries with an open portfolio of 265+ growing businesses.
Maryland Technology Development Corporation is state-formed and state-run firm that¬†specializes in start up, seed, and early stage businesses.¬† With the top ranking nationwide for largest amounts of investments five years running, the organization funds research and development innovation for technology and technology-based¬†businesses.
General Catalyst Partners provides venture capital and growth equity to companies in the areas of new media and Internet, clean energy, and software/systems/services.¬† Growth equity funding amounts can range from $10 million to $50 million to support acquisition and organic growth, recapitalizations, spin-outs, and buyouts.
Forward Ventures is a life sciences and medical device investment company and represents one of the premiere west coast venture capital firms out there today. Based in California, they are searching for business dedicated to creating and commercializing treatments for diseases.¬† Since its inception in 1993, Forward Ventures has invested in more than 50 companies and has $500 million in funds under management.
Domain Associates Llc has been providing private/public equity to life sciences companies, including pharmaceuticals, specialty pharmaceuticals, and medical devices, since 1985.¬† With a total of $2.5 billion in funds under management, Domain Associates supports companies from early to public status alike in financing needs.